CR Bard 1Q profit rises 5 percent as sales improve

CR Bard 1st-quarter profit grows on better sales of vascular, urology, and oncology products

RELATED QUOTES

SymbolPriceChange
BCR105.14-0.01

MURRAY HILL, N.J. (AP) -- Medical device maker C.R. Bard Inc. said Tuesday that its profit rose 5 percent in the first quarter on higher sales in most of its businesses.

Bard said its profit grew to $138.7 million, or $1.60 per share, from $131.9 million, or $1.49 per share, in the year-ago quarter. It reported income of $1.61 per share excluding one-time costs. Revenue increased 4 percent, to $730 million from $700.3 million.

Analysts expected profit of $1.57 per share and revenue of $733.2 million, according to FactSet.

Bard said sales of vascular products rose 5 percent to $209.2 million, while urology product revenue grew 3 percent to $185.1 million and cancer treatment revenue rose 7 percent to $198.9 million. Sales of surgical specialty products edged down to $114.7 million from $114.9 million.

Shares of C. R. Bard rose 15 cents to close at $97.98.

  •  
    Recent Quotes
    Symbol Price Change % ChgChart 
    Your most recently viewed tickers will automatically show up here if you type a ticker in the "Enter symbol/company" at the bottom of this module.
    You need to enable your browser cookies to view your most recent quotes.
  • Recent Quotes News

    •  
      Sign-in to view quotes in your portfolios.

    Trading Center

    Yahoo! Finance on Facebook

    POLL

    In the wake of the Washington state bridge collapse, would you support a tax hike for infrastructure projects?

    Loading...
    Poll Choice Options